Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 17 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
15 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Perrigo Europe Invest from Gent, company number BE0439658834, closed financial year 2025 with a result of € 40.9 million after tax. Compared with financial year 2023, the result moved from € 43.4 million to € 40.9 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
€ 1.7 billion
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 40.9 million
▼ 6% vs 2023
Profit after tax over the fiscal year.
€ 39.5 million paid out
97 % of the profit went to the shareholders, mostly to Perrigo Ireland 2 DAC (98 % of the shares). That is where the money ends up.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 26,898
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 154 days on average.
| 2021 | 2022 | 2023 | 2025 | Change 2023 → 2025 | |
|---|---|---|---|---|---|
| Profit after taxes | € 44,672,923 | € 50,495,209 | € 43,384,345 | € 40,894,317 | ▼ 6% |
| Equity | € 1,393,055,993 | € 1,672,711,663 | € 1,673,096,009 | € 1,675,448,756 | |
| Total debts | € 33,336,810 | € 37,841,163 | € 43,004,428 | € 39,526,898 | ▼ 8% |
| Retained profit | € 53,566,851 | € 49,062,059 | € 49,446,405 | € 51,799,152 | ▲ 5% |
| Dividend | € 60,000,000 | € 55,000,000 | € 43,000,000 | € 39,500,000 | ▼ 8% |
| Balance sheet total | € 1,426,392,802 | € 1,710,552,826 | € 1,716,100,437 | € 1,714,975,654 |
Key figures of Perrigo Europe Invest, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Perrigo Europe Invest?
What happened at Perrigo Europe Invest in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jonas Dhaenens stepped down as director. NBB
- Sonia Hollies stepped down as director. NBB
- Magali Verbraeken stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 40.9 million (▼ 6% vs 2023). Source: NBB ↗
- Anja van Winsberghe stepped down as director. NBB
- Jonas Dhaenens became a director. NBB
- Sonia Hollies became a director. NBB
- Magali Verbraeken became a director. NBB
In short
From € 44.7 million profit in 2021 to € 40.9 million profit in 2025.
Best year ever: 2022, with € 50.5 million profit.
Paid out € 197.5 million in dividends to the owners in total.
Pays suppliers within 154 days on average.
Management
The shares are held by Perrigo Ireland 2 DAC (98.3%). It owns 99.2% of Perrigo Holding itself.
Directors
According to the 2025 annual accounts
Magali Verbraeken
Director
Also active at: MEDGENIX BENELUX, OMEGA PHARMA TRADING, Perrigo Belgium, Perrigo Capital, Oce-Bio, JAICO R.D.P., OMEGA PHARMA INTERNATIONAL, OMEGA PHARMA INNOVATION & DEVELOPMENT
since 2023 · until 2029
Anja van Winsberghe
Director
Also active at: MEDGENIX BENELUX, OMEGA PHARMA TRADING, Perrigo Belgium, Perrigo Capital, Perrigo Holding, Oce-Bio, JAICO R.D.P., HRA PHARMA BENELUX +2 more
since 2021 · until 2026
Sonia Hollies
Director
Also active at: Perrigo Capital, OMEGA PHARMA INTERNATIONAL, OMEGA PHARMA INNOVATION & DEVELOPMENT
since 2024 · until 2030
Jonas Dhaenens
Director
Also active at: OMEGA PHARMA TRADING, Perrigo Capital, Perrigo Holding, Oce-Bio, OMEGA PHARMA INTERNATIONAL, OMEGA PHARMA INNOVATION & DEVELOPMENT
since 2026 · until 2032
Shareholders
Perrigo Ireland 2 DAC
98.3%
Participations
99.2%
Establishments
Establishment units
Physical locations of this company
Gaston Crommenlaan 6 box 606
9050 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 15 companies are registered at this address.
All companies at this address →OMEGA PHARMA TRADING same network
€ 538,596 revenue · 2025
Perrigo Belgium same network
€ 44.6 million revenue · 2025
Perrigo Capital same network
€ 2.2 million revenue · 2025
Perrigo Holding same network
€ 48.4 million revenue · 2025
Oce-Bio same network
€ 4.1 million revenue · 2025
+10 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0439.658.834
- VAT number
- BE 0439.658.834
- Registered office
- Gaston Crommenlaan 6 bus 606, 9050 Gent
- Names & denominations
- Perrigo Europe Invest
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 20 December 1989
- Peppol
- Active · Active since 8 Dec 2025